GlassScriptPhysician profile
Allan D Macintyre
NPI 1609854405
$2,006.51
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $829 · 2021: $378 · 2022: $31.02 · 2023: $511 · 2024: $47.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $339 · Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $339.20 |
| Food and Beverage | $219.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $430.32 | 2020-2021 | |
| Acera Surgical, INC. | $386.04 | 2023 | Restrata Wound Matrix |
| Intuitive Surgical, INC. | $372.87 | 2019-2020 | |
| Stability Biologics, LLC | $289.64 | 2020-2021 | |
| Melinta Therapeutics, LLC | $125.00 | 2023 | Kimyrsa |
| Integra Lifesciences Corporation | $114.49 | 2020 | |
| Avita Medical Americas, LLC | $47.54 | 2024 | |
| Teleflex LLC | $44.42 | 2019 | |
| Ethicon US, LLC | $43.90 | 2019-2022 | |
| Biom'Up France Sas | $35.38 | 2021 | |
| Organogenesis INC. | $30.33 | 2021 | |
| Covidien LP | $27.12 | 2019 | |
| Cook Medical LLC | $24.28 | 2019 | |
| Kci USA, INC. | $18.41 | 2022 | |
| Kls-Martin L.P. | $16.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Macintyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.